Proassurance | 10-Q: FY2025 Q3 Revenue: USD 279.55 M

LB filings
2025.11.04 21:42
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q3, the actual value is USD 279.55 M.

EPS: As of FY2025 Q3, the actual value is USD 0.03, missing the estimate of USD 0.27.

EBIT: As of FY2025 Q3, the actual value is USD 9.605 M.

Specialty Property and Casualty (Specialty P&C) Segment

  • Net Premiums Earned: $180.8 million for Q3 2025, $543.4 million for the nine months ended September 30, 2025.
  • Net Losses and Loss Adjustment Expenses: $149.3 million for Q3 2025, $425.3 million for the nine months ended September 30, 2025.
  • Operating Expenses: $24.1 million for Q3 2025, $72.8 million for the nine months ended September 30, 2025.
  • Deferred Policy Acquisition Costs: $26.8 million for Q3 2025, $73.8 million for the nine months ended September 30, 2025.
  • Segment Results: Loss of $18.5 million for Q3 2025, loss of $21.6 million for the nine months ended September 30, 2025.

Workers’ Compensation Insurance Segment

  • Net Premiums Earned: $41.0 million for Q3 2025, $124.0 million for the nine months ended September 30, 2025.
  • Net Losses and Loss Adjustment Expenses: $30.7 million for Q3 2025, $92.0 million for the nine months ended September 30, 2025.
  • Operating Expenses: $11.5 million for Q3 2025, $33.3 million for the nine months ended September 30, 2025.
  • Deferred Policy Acquisition Costs: $4.3 million for Q3 2025, $14.9 million for the nine months ended September 30, 2025.
  • Segment Results: Loss of $5.1 million for Q3 2025, loss of $14.9 million for the nine months ended September 30, 2025.

Segregated Portfolio Cell Reinsurance Segment

  • Net Premiums Earned: $11.6 million for Q3 2025, $34.7 million for the nine months ended September 30, 2025.
  • Net Losses and Loss Adjustment Expenses: $6.1 million for Q3 2025, $18.7 million for the nine months ended September 30, 2025.
  • Operating Expenses: $0.4 million for Q3 2025, $1.3 million for the nine months ended September 30, 2025.
  • Deferred Policy Acquisition Costs: $3.7 million for Q3 2025, $10.9 million for the nine months ended September 30, 2025.
  • Segment Results: Profit of $0.9 million for Q3 2025, profit of $2.7 million for the nine months ended September 30, 2025.

Corporate Segment

  • Net Investment Income: $39.3 million for Q3 2025, $113.5 million for the nine months ended September 30, 2025.
  • Equity in Earnings of Unconsolidated Subsidiaries: $4.7 million for Q3 2025, $13.3 million for the nine months ended September 30, 2025.
  • Net Investment Gains (Losses): $0.0 million for Q3 2025, loss of $2.4 million for the nine months ended September 30, 2025.
  • Other Income (Expense): Loss of $1.0 million for Q3 2025, loss of $10.0 million for the nine months ended September 30, 2025.
  • Interest Expense: $5.2 million for Q3 2025, $15.6 million for the nine months ended September 30, 2025.
  • Segment Results: Profit of $27.1 million for Q3 2025, profit of $65.0 million for the nine months ended September 30, 2025.

Outlook and Strategy

  • Merger Agreement: ProAssurance entered into a merger agreement with The Doctors Company, with an anticipated closing by June 30, 2026, subject to regulatory approvals.
  • Transaction-Related Costs: Approximately $3.0 million and $14.6 million in pre-tax transaction-related costs were incurred during the three and nine months ended September 30, 2025, respectively.
Source: LB filings The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer